Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DN.TO
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Delta 9 Cannabis Inc
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 3.02M
- Ent value
- 81.94M
- Price/Sales
- 0.04
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -3.25%
- 1 year return
- -81.82%
- 3 year return
- -71.46%
- 5 year return
- -59.16%
- 10 year return
- -27.83%
Last updated: 2024-12-17
DIVIDENDS
DN.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 0.71 |
| Price to FCF | 0.74 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.04 |
| Price to Book | - |
| EV to Sales | 1.16 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 302.18M |
| EPS (TTM) | -0.08 |
| FCF per share (TTM) | 0.02 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 70.65M |
| Gross profit (TTM) | 14.14M |
| Operating income (TTM) | -15.22M |
| Net income (TTM) | -19.60M |
| EPS (TTM) | -0.08 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 20.01% |
| Operating margin (TTM) | -21.54% |
| Profit margin (TTM) | -27.74% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.27M |
| Net receivables | 2.26M |
| Total current assets | 16.22M |
| Goodwill | 14.20M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 65.33M |
| Total assets | 70.23M |
| Accounts payable | 2.93M |
| Short/Current long term debt | 64.60M |
| Total current liabilities | 54.87M |
| Total liabilities | 80.19M |
| Shareholder's equity | -9.96M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 4.23M |
| Capital expenditures (TTM) | 116.97K |
| Free cash flow (TTM) | 4.11M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -27.91% |
| Return on Invested Capital | 547.62% |
| Cash Return on Invested Capital | -114.82% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| DN.TO | S&P500 | |
| Current price drop from All-time high | -99.73% | -1.53% |
| Highest price drop | -99.73% | -56.47% |
| Date of highest drop | 22 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -73.22% | -11.07% |
| Avg time to new high | 105 days | 12 days |
| Max time to new high | 1700 days | 1805 days |
COMPANY DETAILS
Marketcap
3.02M
Marketcap category
Small-cap
Description
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.
Employees
200
Website
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found